Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

After the 2024 U.S. election, Vermont Senator Bernie Sanders delivered a sharp critique of the Democratic party, asserting ...

A day after the warning landed on semaglutide labels, Novo Nordisk CEO Lars Fruergaard Jørgensen said he is alarmed by the amount of unsafe compounded GLP-1s in the U.S. market, adding that the ...

Regeringens nye life science-strategi vil styrke den danske nøglesektors konkurrenceevne. Den bør inspirere et udfordret ...

Selv om efterspørgslen giver muligheder for langt højere vækst, kan Novo Nordisk ikke vokse hurtigere, end fabrikkerne kan ...

Lars Fruergaard Jørgensen, Novo Nordisk CEO, joins 'Money Movers' to discuss Jorgensen's comments on demand in 2025, if demand is waning for GLP-1 drugs, and much more.

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

Bruger milliarder på ekstremist Bernie Sanders mener slet og ret, at den siddende administration har mistet befolkningens opbakning. Det har den, blandt andet, fordi den bruger milliarder af dollars ...

Trumps handelspolitik kan gå hen og få store konsekvenser for danske virksomheder. En virksomhed på Sjælland fortæller, at de ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...